The World Health Organization (WHO) has officially recommended the use of a new class of weight-loss drugs to treat obesity and diabetes globally. These drugs, known as GLP-1 agonists, include popular brands like Ozempic, Wegovy, and Mounjaro. WHO’s endorsement marks the first time these medications have been acknowledged as essential for treating obesity, which affects […]